Changing smoking behavior in LGBTQ+ young adults through targeted messaging
The Effect of Nicotine and Tobacco Message Framing on Use Among Diverse Groups of Young Adults: Aim 3 Randomized Control Trial (RCT)
This study is testing if different types of messages can help LGBTQ+ young adults reduce their smoking and tobacco use over six weeks.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 300 (estimated) |
| Ages | 18 Years to 35 Years |
| Sex | All |
| Sponsor | Ohio State University Comprehensive Cancer Center Academic / other |
| Locations | 1 site (Columbus, Ohio) |
| Trial ID | NCT06644664 on ClinicalTrials.gov |
What this trial studies
This clinical trial evaluates how different messaging strategies can influence smoking behaviors among LGBTQ+ young adults who use nicotine and/or tobacco products. Participants will receive mobile multimedia messaging (MMS) with either absolute or relative risk information about polytobacco use, or control messages about UV exposure, over a six-week period. The study aims to assess the feasibility of delivering these messages and to estimate their effects on participants' risk perceptions and tobacco use over time. Follow-up assessments will occur at 6 and 12 weeks post-intervention to evaluate changes in smoking behavior.
Who should consider this trial
Good fit: Ideal candidates are LGBTQ+ young adults aged 18-35 who currently use electronic nicotine delivery systems or combustible tobacco.
Not a fit: Patients who do not identify as LGBTQ+ or do not currently use tobacco products may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to more effective smoking cessation strategies tailored for LGBTQ+ young adults.
How similar studies have performed: Other studies have shown promise in using targeted messaging to influence health behaviors, suggesting potential success for this approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * 18-35 years old * Self-identify as LGBTQ+ * Able to speak English fluently * An ever user of ENDS and combustible tobacco who currently use ENDS, combustible cigarettes, or both ENDS and combustible cigarettes * Currently reside in the United States (US) * Have a mobile phone through a U.S. carrier with MMS messaging and can send and receive text messages for study participation * Access to the internet with Zoom capabilities Exclusion Criteria: * Have a landline or Voice Over Internet Protocol (VOIP) phone number
Where this trial is running
Columbus, Ohio
- Ohio State University Comprehensive Cancer Center — Columbus, Ohio, United States (Recruiting)
Study contacts
- Principal investigator: Joanne G Patterson — Ohio State University Comprehensive Cancer Center
- Study coordinator: The Ohio State University Comprehensive Cancer Center
- Email: OSUCCCClinicaltrials@osumc.edu
- Phone: 800-293-5066
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.